NCT05709574View on ClinicalTrials.gov

Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 20, 2023

Primary Completion Date

March 30, 2026

Study Completion Date

May 31, 2026

Conditions
Gastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Interventions
DRUG

Tadalafil 20 MG

Tadalafil 20 mg tablets will be taken daily for 2 weeks alone and then for 8 weeks in combination with neoadjuvant chemotherapy in the window between gastric/GEJ adenocarcinoma diagnosis and interventional surgery.

Trial Locations (1)

85719

RECRUITING

Arizona Cancer Center at UMC North/University Medical Center, Tucson

All Listed Sponsors
lead

University of Arizona

OTHER